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Abstract
Spontaneous intracranial hypotension (SIH) is caused by cerebrospinal fluid (CSF) leakage. Pa-
tients with SIH experience postural headaches, nausea, etc., due to CSF hypovolemia. Imaging 
studies and clinical examinations, such as radioisotope (RI) scintigraphy, are useful for diagnosing 
SIH. However, 20-30% of patients do not show typical morphology and clinical test results. We 
previously reported that CSF contains transferrin (Tf) isoforms: “brain-type” Tf derived from the 
choroid plexus and “serum-type” Tf derived from blood. We showed that both isoforms increased 
in the CSF of patients with SIH by Western blotting. In the present study, we demonstrate that 
conventional ELISA for quantifying total Tf is useful for diagnosing SIH more accurately than West-
ern blotting. In addition, SIH with chronic subdural hematoma (CSDH) was also accurately diagnosed.　
Total Tf in the CSF can serve as a useful biomarker for diagnosing SIH with or without CSDH.
Key words : chronic subdural hematoma (CSDH), enzyme-linked immunosorbent assay (ELISA), 
spontaneous intracranial hypotension (SIH), transferrin (Tf)
Introduction
Cerebrospinal fluid (CSF) physically cushions 
the brain and the spinal cord. Normally, CSF circu-
lates and is constantly replenished. CSF is pro-
duced by the choroid plexus and secreted into the 
ventricles of the brain. The constant secretion of 
CSF contributes to vital functions such as providing 
nourishment, waste removal, and protection to the 
brain.
Spontaneous intracranial hypotension (SIH) is 
caused by CSF leak, and the resulting CSF hypovo-
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lemia leads to orthostatic headaches. Clinical eval-
uation shows low intracranial pressure (ICP) and dif-
fuse pachymeningeal enhancement on magnetic 
resonance imaging (MRI)1-4). Brain MRI and radio-
isotope (RI) cisternography can be used to identify 
SIH. Although these clinical tests are useful, 20-
30% of patients with SIH do not show the typical 
manifestations3). New tests and biomarkers are re-
quired for accurate diagnosis and timely interven-
tion.
Transferrin (Tf) is an iron-binding protein se-
creted from the liver that carries iron to other or-
gans via the blood stream5,6). In previous studies, 
we identified two isoforms of Tf, with different gly-
cosylation patterns, in the CSF. One isoform was 
designated as “serum-type” Tf, or Tf-2, which has 
glycans like those of serum transferrin, suggesting 
that the isoform is derived from blood. The other 
isoform, designated as “brain-type” Tf, or Tf-1, was 
detected in the CSF but not in serum7-9). Brain-
type Tf was undetectable in the CSF of patients with 
hydranencephaly, lacking cerebral hemispheres, sug-
gesting that brain-type Tf is of hemispheric origin10).　
We found that both isoforms were increased in the 
CSF of patients with SIH11), suggesting that Tf iso-
forms could be a new diagnostic marker for SIH.
Although each isoform was quantified by West-
ern blotting, this method is time- and labor-consum-
ing. In contrast, conventional ELISA is fast, sensi-
tive, reproducible, and operationally high-throughput, 
but it does not distinguish Tf isoforms.　This study 
aimed to demonstrate the usefulness of “total” Tf 
quantified by conventional ELISA in diagnosing SIH.
Materials and methods
Patients
We consecutively recruited patients suspected 
of SIH by lumbar puncture at the Sanno Hospital, as 
previously described11). In brief, patients were di-
agnosed by clinical presentation, particularly ortho-
static headache, MRI and/or computed tomography 
(CT), and RI scintigraphy. The diagnosis of SIH 
was based on the International Classification of 
Headache Disorders, 3rd edition (beta version)12) 
and the diagnostic criteria reported by Schievinket et 
al.13) as follows: (1) Morphological evidence of CSF 
leakage such as pachymeningeal enhancement on 
cranial MRI (Fig. 1) and/or low CSF opening pres-
sure (≤60 mm H2O). (2) No recent history of dural 
puncture. (3) Not attributable to another disorder.　
Non-SIH patients were defined as those suspected 
of SIH based on clinical presentation, but not fulfill-
ing any of the above criteria. This study was ap-
proved by the Ethics Committees of Sanno Hospital 
(Approval No. 14-S-17 and 14-S-18) and Fukushima 
Medical University (Approval No. 2466), which are 
guided by local policy, national law, and the World 
Medical Association Declaration of Helsinki.
CSF
CSF samples from 150 patients were analyzed.　
Tf isoforms, rather than total Tf, were analyzed in 
58 of 150 patients by Western blot in our previous 
study; these data were included in the present 
study, along with 92 new Western blot cases, all 150 
Fig 1. Cranial magnetic resonance imaging of patients without spontaneous intracranial hypotension (non-SIH), 
SIH, and SIH with chronic subdural hematoma (SIH+CSDH).
 MRI image of a non-SIH patient (A). Diffuse pachymeningeal gadolinium enhancement (arrowhead in the upper 
panel) and enlarged pituitary, cerebellar tonsil descent, and intracranial venous dilatation (arrows a, b, c respec-
tively, in the lower panel) is shown with an SIH patient (B). In addition to these findings, a patient with 
SIH+CSDH patient has subdural hematoma (arrowhead in the upper panel) (C).
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of which were also investigated with conventional 
ELISA. Patients were categorized into non-SIH, 
SIH, or SIH with CSDH (SIH+CSDH) groups. In 
the non-SIH group, there were 35 subjects (16 
males and 19 females) with a mean age of 36.9 ± 
18.4 years (range, 9-72 years). SIH (SIH without 
CSDH) was diagnosed in 57 cases (20 males and 37 
females), mean age 39.4 ± 9.0 years (range, 26-64 
years). SIH+CSDH was diagnosed in 58 cases (36 
males and 22 females), mean age 48.9 ± 11.3 years 
(range, 20-77 years). CSF samples were with-
drawn after the measurement of ICP, and were cen-
trifuged to remove cells and debris. What remained 
was stored in polypropylene tubes at −80°C until 
analysis.
Conventional ELISA
Total concentration of Tf was measured in CSF 
as follows. A 96-well plate was coated with anti-Tf 
polyclonal antibody (Bethyl laboratories, 1 : 1,000) at 
4°C overnight, and blocked with 0.5% bovine serum 
albumin (BSA) for 2 h at room temperature. Each 
CSF sample (1 : 6,000-70,000 dilution) was added 
and incubated for 2 h at 20°C, and then incubated 
with a horseradish peroxidase (HRP)-conjugated 
goat antihuman Tf antibody (Bethyl laboratories, 
1 : 20,000) for 2 h at 20°C. The signal was detected 
with a TMB Microwell Peroxidase Substrate System 
(KPL, 50-76-11) and quantified by Plate CHAME-
LEON (Hidex), with apo-Transferrin (Sigma, T4382) 
used as a standard.
Western blotting
We quantified Tf isoforms, brain-type and se-
rum-type (formerly Tf-1 and Tf-2, respectively) by 
immunoblotting as previously described11). Briefly, 
each CSF sample was dissolved in sample buffer and 
boiled for 5 min. The CSF sample was loaded onto 
7.5% SDS-polyacrylamide gels (SuperSepTM Ace; 
Wako Pure Chemical Industries, Osaka, Japan) and 
transferred to nitrocellulose membranes. After 
blocking the membrane with 3% skim milk in phos-
phate-buffered saline with Tween (PBST), and incu-
bating sequentially with an anti-Tf antibody (Bethyl 
Laboratories) and an HRP-labeled anti-goat IgG 
(Jackson ImmunoResearch Laboratories, West 
Grove, PA), the protein was detected using a Super-
Signal West Dura Chemiluminescence Substrate Kit 
(Pierce Biotechnology, Rockford, IL). Signal inten-
sities were quantified by chromato-scanning with a 
CS Analyzer 2.0 (ATTO, Tokyo, Japan).
Measurement of ICP and RI residual activity
ICP and RI residual activity in the CSF was cal-
culated as previously described11).
Statistical analyses
Statistical analyses for non-SIH, SIH and SIH 
+CSDH were determined to be non-parametric by 
the Kruskal-Wallis test. We checked for correla-
tions between total Tf and the two Tf isoforms or 
two clinical tests, and ICP and RI residual activity, 
using Spearman’s rank correlation coefficient. Sta-
tistical analyses were performed using SPSS Statis-
tics software (IBM Japan).
Results
MRI of non-SIH, SIH, and SIH+CSDH patients
Medical imaging is valuable for the diagnosis of 
CSF leakage. SIH has some characteristic imaging 
features14). In Fig. 1, cranial MRI reveals that dif-
fuse pachymeningeal gadolinium enhancement is 
observed in SIH (Fig. 1B, in the upper panel), and 
that typical signs of intracranial hypotension are also 
observable; i.e., intracranial venous dilatation, en-
larged pituitary, and cerebellar tonsil descent (a, b, 
and c, respectively, in the lower panels of Fig. 1B 
and C). In addition, subdural hematoma was ob-
served in a patient with SIH+CSDH (Fig. 1C, upper 
panel). Conversely, one non-SIH patient did not 
show morphological changes (Fig. 1A).
Increase of Tf levels in the CSF of patients with SIH 
and SIH+CSDH.
We analyzed Tf isoforms in the CSF by Western 
blotting: brain-type Tf (Tf-1) derived from the cho-
roid plexus and serum-type Tf (Tf-2) from blood.　
We previously reported that the levels of brain-type 
Tf and serum-type Tf were elevated in SIH. In pa-
tients with non-SIH, SIH, and SIH+CSDH, brain-
type Tf levels (mean ± S.D.) were 7.7 ± 3.5 ng/µL, 
14.7 ± 7.1 ng/µL, and 14.5 ± 6.6 ng/µL, respective-
ly, whereas those of serum-type Tf were 18.9 ± 6.0 
ng/µL, 38.4 ± 36.4 ng/µL, and 38.0 ± 22.6 ng/µL, 
respectively. Subsequently, we investigated total 
Tf concentration in the CSF by conventional ELISA.　
As shown in Fig. 2, total Tf levels were higher in pa-
tients with SIH and SIH+CSDH than in those with 
non-SIH. The total Tf levels were 16.4 ± 7.2 ng/
µL in the non-SIH group, 42.1 ± 33.6 ng/µL in the 
SIH group, and 42.0 ± 28.4 ng/µL in the SIH+ 
CSDH group (Fig. 2), indicating that conventional 
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ELISA differentiates non-SIH from SIH and SIH+ 
CSDH. No significant differences emerged in Tf 
concentrations of patients with SIH versus SIH+ 
CSDH using the conventional ELISA or Western 
blotting.
Superiority of conventional ELISA over Western blot-
ting as a diagnostic tool for SIH and SIH+CSDH.
Data obtained by conventional ELISA and West-
ern blotting were statistically analyzed and com-
pared for their diagnostic accuracy. We established 
the validity of conventional ELISA as a diagnostic 
tool for SIH and SIH+CSDH by quantifying its sen-
sitivity and specificity as a clinical test. In SIH, the 
sensitivity and specificity based on conventional 
ELISA data were 86.0% and 77.1%, respectively.　
Western blotting data showed sensitivities and spec-
ificities in the range of 78.9-84.2% and 74.3-77.1%, 
respectively (Table 1), indicating that conventional 
ELISA is more accurate than Western blotting.　
The diagnostic accuracy was also high for SIH+ 
CSDH. The combined data of all patients with SIH 
(SIH and SIH+CSDH) indicates a sensitivity and 
specificity of 87.0% and 77.1% in conventional ELI-
SA, versus 80.0-83.5% and 74.3-77.1% in Western 
blotting, respectively. Conventional ELISA showed 
high sensitivity and specificity in addition to being 
faster and having high throughput and reproducibili-
ty. These results show the superiority of conven-
tional ELISA over Western blotting as a diagnostic 
tool for SIH and SIH+CSDH.
Correlation between the levels of total Tf and brain-
type Tf or serum-type Tf
The correlation coefficient of total Tf was ex-
amined with the Tf isoforms. Data of SIH and 
SIH+ CSDH were combined for the analysis (all 
SIH patients) (Fig. 3). In non-SIH, total Tf corre-
lated well with Tf isoforms; r = 0.697 for brain-type 
Tf, r = 0.778 for serum-type Tf, r = 0.776 for brain-
type Tf +serum-type Tf (Fig. 3). The correlation 
coefficient of SIH and SIH+CSDH (all patients with 
Fig 2. The levels of transferrin (Tf) in cerebrospinal fluid (CSF) are increased in patients with spontaneous intracra-
nial hypotension (SIH) and SIH with chronic subdural hematoma (SIH+CSDH).
 Tf concentration was measured in the CSF of non-SIH (n = 35), SIH (n = 57) and SIH+CSDH (n = 58) pa-
tients. Total Tf is by conventional ELISA (A). Brain- and serum-type Tf is detected by Western Blotting (B, 
C). **p < 0.01
Table 1. Sensitivity and specificity analysis.
SIH SIH+CSDH all SIH patients 
SN (%) SP (%) SN (%) SP (%) SN (%) SP (%)
ELISA Total Tf 86.0 77.1 82.8 85.7 87.0 77.1
WB Brain-type Tf 78.9 77.1 81.0 80.0 82.6 74.3
Serum-type Tf 84.2 74.3 82.8 74.3 83.5 74.3
Brain-type + Serum-type Tf 80.7 77.1 79.3 77.1 80.0 77.1
SN : sensitivity, SP : specificity, all SIH patients : Combined data of SIH and SIH+CSDH
SIH : spontaneous intracranial hypotension
SIH+CSDH : spontaneous intracranial hypotension with chronic subdural hematoma
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SIH) was 0.596-0.845, and was similar to that of 
non-SIH. 
Correlation between total Tf and quantitative clinical 
tests for SIH.
Measurements of ICP and RI residual activity 
have been established as diagnostic tools for differ-
entiating SIH from non-SIH15,16). These clinical 
tests were examined for their correlations with total 
Tf concentration in the CSF. Fig. 4 illustrates that 
a decrease in ICP is inversely correlated with an in-
crease in total Tf in all SIH patient groups (combined 
data of SIH and SIH+CSDH) (r = −0.429, p < 0.01) 
(Fig. 4, left panel). In addition, a decrease of RI re-
sidual activity is inversely correlated with an in-
crease in Tf concentration in the CSF of these pa-
tients (r = −0.414, p < 0.01) (Fig. 4, right panel).　
In the SIH group, the cutoff of ICP was set at 9.7 
mm H2O and the cutoff of RI residual activity at 24 h 
after RI injection was set at 20%. The cutoff of to-
tal Tf in all SIH groups was set at 17.96 ng/μL.　
When the ICP cutoff is set at 9.7 mm H2O, all SIH 
patients is distinguished from non-SIH with 79.4% 
sensitivity and 65.1% specificity. When the cutoff 
of RI residual activity is set at 20%, all SIH patients 
were differentiated from non-SIH with 64.7% sensi-
tivity and 91.3% specificity. As shown in Table 1, 
total Tf shows 87.0% sensitivity and 77.1% specifici-
ty for the differentiation, indicating that total Tf is a 
supportive biomarker for diagnosing SIH including 
SIH+CSDH.
Discussion
The diagnosis of SIH is based on a combination 
of clinical features and imaging methods12,13). SIH 
is characterized by low CSF pressure and orthostatic 
headaches caused by CSF leakage but orthostatic 
headache is a non-specific complaint with variable 
manifestations. Medical imaging is valuable for the 
diagnosis of CSF leakage; e.g., cranial MRI reveals 
that SIH has characteristic anatomic features (Fig. 
1).
In previous studies, we identified two isoforms 
of Tf, brain-type Tf and serum-type Tf, on Western 
blot (WB). Both isoforms were elevated in the 
CSF of patients with SIH11). This prompted us to 
investigate other laboratory methods to measure Tf 
in CSF, because WB is not suitable for routine clini-
cal use due to time- and labor-consuming features.　
Our WB protocol takes 3 days, with a batch limit of 
20 specimens. In addition, purified brain-type and 
serum-type standards are required for quantification.　
In contrast, conventional ELISA is widely available 
on commercial platforms, and the assay can be com-
pleted within a day. Clinical laboratory staff are 
usually familiar with ELISA.　This facilitates its 
clinical utility for measuring Tf to diagnose SIH.
In Fig. 2, Western blotting and conventional 
ELISA showed that total Tf levels are elevated in 
SIH+ CSDH in addition to SIH, suggesting that to-
tal Tf could be a new diagnostic marker for SIH.
Although Tf isoforms are not distinguishable 






































































































































Fig 3. Correlation coefficient analysis on total transferrin (Tf) and Tf isoform levels.
 Data obtained by conventional ELISA and Western blotting were subjected to correlation coefficient analy-
sis. The cohort was divided into controls without spontaneous intracranial hypotension (non-SIH) and all SIH 
patients, which included SIH only and SIH with chronic subdural hematoma (SIH+CSDH). Total Tf was mea-
sured by conventional ELISA. Brain and serum-type Tf were quantified by Western blotting.
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valuable due to its speed, sensitivity, throughput, 
and reproducibility. A receiver operating character-
istic (ROC) curve shows the relationship between 
clinical sensitivity and specificity; sensitivity indi-
cates the ability to correctly generate a positive test 
result for persons who have the disease (true posi-
tive);  specificity shows the ability to correctly gen-
erate a negative test result for persons who do not 
have the disease (true negative). From sensitivity 
and specificity analyses, conventional ELISA shows 
better accuracy than Western blotting for diagnosing 
SIH and SIH+CSDH (Table 1). Next, we examine 
correlations between the levels of brain-type Tf and 
serum-type Tf, individually and combined (Fig. 3).　
The correlation coefficient of all patients with SIH is 
smaller than that of non-SIH.　In particular, brain-
type Tf do not show high correlation (r = 0.523), 
suggesting that the levels of brain-type Tf are differ-
entially controlled under CSF leakage. The corre-
lation coefficient of total Tf is similar to that of se-
rum-type Tf in non-SIH and all patients with SIH, 
possibly because total Tf was mainly composed of 
serum-type Tf (70～80%).
SIH is caused by CSF leakage from the sub-
arachnoid space. The loss of CSF decreases ICP.　
CSF leakage can be estimated by RI cisternography. 
RI injected into the subarachnoid space rapidly de-
creases due to CSF leakage, resulting in low RI re-
sidual activity. Since RI cisternography and ICP 
measure have been established as diagnostic tools 
for differentiating SIH from non-SIH15,16), we exam-
ine correlations between total Tf and the clinical 
tests for SIH (Fig. 4).　A decrease in ICP or RI re-
sidual activity was inversely correlated with an in-
crease of total Tf in all SIH patient groups.　Fur-
thermore, conventional ELISA for measuring total 
Tf yielded better ROC curves for the differential di-
agnosis than clinical tests.　These results indicates 
the use of total Tf measured by conventional ELISA 
is a biomarker for diagnosing SIH including SIH+ 
CSDH. Conventional ELISA is an excellent sys-
tem that can measure many samples simultaneously 
with few errors. It is expected that this system 
will contribute not only to the diagnosis of SIH, but 
also, to the assessment of other brain diseases in the 
future.
We showed that two isoforms of Tf increase in 
the CSF of patients with SIH, and that total Tf can 
serve as a biomarker for SIH with and without 
CSDH. Beyond the immediate utility of transferrin 
as a biomarker for SIH, our results indicate that 
iron-related conditions such as anemia and chronic 
infection should be further investigated in the con-
text of patients with SIH and other neurological con-
ditions.
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Fig 4. Correlation between CSF total transferrin (Tf) and clinical tests such as intracranial pressure (ICP) and radio-
isotope (RI) residual activity.
 Decrease of ICP and RI residual activity were inversely correlated with increases of total Tf. Patients include 
those with spontaneous intracranial hypotension (SIH) and SIH with chronic subdural hematoma (SIH+CSDH) 
(all SIH patients). Total Tf was measured by conventional ELISA.
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